Mucopolysaccharidosis Type VI · Maroteaux-Lamy syndrome · Arylsulfatase B deficiency · Maroteaux-Lamy-Syndrom
Mucopolysaccharidosis VI (MPS VI) is an inherited metabolic disease where the body lacks a specific enzyme called arylsulfatase B. Without this enzyme, complex sugar molecules called glycosaminoglycans cannot be broken down and instead build up to harmful levels in the body's tissues. This accumulation primarily damages the skeletal system, joints, and eyes.
Symptoms usually become visible within the first few months of life. Owners may notice unusually short stature (dwarfism), skeletal deformities, cloudy eyes, joint pain, and a progressive loss of mobility or paralysis.
There is no cure for this progressive condition, so treatment focuses entirely on managing pain and maintaining comfort. Lifelong supportive care is required, with estimated veterinary costs ranging from €2,000 to €7,000.
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.
More conditions affecting the General / metabolic.